Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
Department of Health and Human Services ▸ National Institutes of Health
Description
Grant summary: Funds research to test how well combined digital health tools help manage diabetes remotely. “Multimodality” means using multiple technologies together (for example, smartphone apps, continuous glucose monitors, wearables, and telehealth). Projects should evaluate both efficacy (works under ideal conditions) and clinical effectiveness (works in real-world care).
This notice of funding opportunity (NOFO) invites applications designed to examine the efficacy and clinical effectiveness of multimodality digital health technology approaches to the remote management of diabetes.
Source
Grant ID
RFA-DK-26-315
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- City or township governments
- County governments
- For profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities/Indian housing authorities
- Small businesses
- Special district governments
- State governments
Links
Documents
Similar opportunities
- Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations
- Innovative Research Projects to Test Strategies for Digital Mental Health Interventions
- Notice of Funding Opportunity for Investigator-Initiated Fully Remotely Delivered and Conducted Clinical Trials
- Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)
- Development and Validation of Digital Health Technology Derived Biomarkers or Clinical Outcome Assessments for Remote Monitoring